Preparation of the iodine-124 derivative of the Bolton-Hunter reagent ([124I]I-SHPP) and its use for labelling a VEGF antibody as a PET tracer

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 45, Issue 12, 2002, Pages 1077-1090

  Glaser, Matthias ^a   Carroll, Veronica A ^b   Collingridge, David R ^a   Aboagye, Eric O ^a   Price, Pat ^a   Bicknell, Roy ^b   Harris, Adrian L ^b   Luthra, Sajinder K ^a   Brady, Frank ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

124I; Angiogenesis; Antibody labelling; Bolton Hunter reagent; VEGF

Indexed keywords

ENDOTHELIAL CELLS;

124I; ANGIOGENESIS; ANTIBODY LABELING; BOLTON-HUNTER REAGENT; LABELINGS; MEASUREMENTS OF; PET TRACER; RADIOCHEMICAL PURITY; RADIOIODINATION; VASCULAR ENDOTHELIAL GROWTH FACTOR;

ANTIBODIES;

BOLTON HUNTER REAGENT I 125; IODINE 124; IODOBENZOIC ACID DERIVATIVE; N SUCCINIMIDYL 3 IODOBENZOATE I 125; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ANGIOGENESIS; ANTIBODY SPECIFICITY; ARTICLE; BINDING ASSAY; CYCLOTRON; IMMUNOREACTIVITY; POSITRON EMISSION TOMOGRAPHY; RADIOIODINATION;

EID: 18744362436     PISSN: 03624803     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlcr.634     Document Type: Article

References (41)

1. O'Reilly MS, Boehm T, Shing Y, et al. Cell 1997; 88: 277-285.
2. O'Reilly MS, Holmgren L, Chen C, Folkman J. Nature Med 1996; 2: 689-692.
3. Westphal JR, Ruiter DJ, De Waal RMW. Int J Cancer 2000; 86: 870-873.
4. Hicklin DJ, Witte L, Zhu Z, et al. Drug Discovery Today 2001; 6: 517-528.
5. Brekken RA, Huang X, King SW, Thorpe PE. Cancer Res 1998; 58: 1952-1959.
6. Kim KJ, Li B, Winer J, Armanini M, Gillet N, Phillips HS, Ferrara N. Nature 1993; 362: 841-844.
7. Jayson GC, Mulatero C, Ranson M, et al. Clin Cancer Res 2000; 6 (suppl.): 4520s.
8. Fraser HM, Dickson SE, Lunn SF, et al. Endocrinology 2000; 141: 995-1000.
9. Pentlow KS, Graham MC, Lambrecht RM, et al. J Nucl Med 1996; 37: 1557-1562.
10. Bakir MA, Eccles SA, Babich JW, et al. J Nucl Med 1992; 33: 2154-2160.
11. Wilson CB, Snook DE, Dhokia B, et al. Int J Cancer 1991; 47: 344-347.
12. Westera G, Reist HW, Buchegger F, et al. Nucl Med Commun 1991; 12: 429-437.
13. Lee FT, Hall C, Rigopoulos A, et al. J Nucl Med 2001; 42: 764-769.
14. Rubin SC, Kairemo KJA, Brownell AL, et al. Gynecol Oncol 1993; 48: 61-67.
15. Daghighian F, Pentlow KS, Larson SM, et al. Eur J Nucl Med 1993; 20: 402-409.
16. Larson SM, Pentlow KS, Volkow ND, et al. J Nucl Med 1992; 33: 2020-2023.
17. Rudinger J, Ruegg U. Biochem J 1973; 133: 538-539.
18. Bolton AE, Hunter WM. Biochem J 1973; 133: 529-539.
19. Bolton AE, Hunter WM. J Endocrinol 1972; 55: 30-31.
20. Vaidyanathan G, Zalutsky MR. Bioconjugate Chem 1990; 1: 269-273.
21. Wilbur DS, Hadley SW, Hylarides MD, et al. J Nucl Med 1989; 30: 216-226.
22. Wilbur DS, Jones DS, Fritzberg AR. J Label Compd Radiopharm 1986; 23: 1304-1306.
23. Zalutsky MR, Narula AS. Appl Radiat Isot 1987; 38: 1051-1055.
24. Wilbur DS. Bioconjugate Chem 1992; 3: 433-470.
25. McGarry TJ, Lambrecht RM, Al-Ahdal M. Med Sci Res 1988; 16: 737-738.
26. Fraker PJ, Speck JC Jr. Biochem Biophys Res Commun 1978; 80: 849-857.
27. Slater RJ. Radioisotopes in Biology - A Practical Approach. Oxford University Press: Oxford, New York, Tokyo, 1993.
28. Garg PK, Alston KL, Welsh PC, Zalutsky MR. Bioconjugate Chem 1996; 7: 233-239.
29. Nikula TK, Bocchia M, Curcio MJ, et al. Mol Immunol 1995; 32: 865-872.
30. Banerjee SP, Cuatrecasas P, Snyder SH. J Biol Chem 1976; 251: 5680-5685.
31. Wood WG, Wachter C, Scriba PC. J Clin Chem Biochem 1981; 19: 1051-1056.
32. Cuatrecasas P, Parikh I. Biochemistry 1972; 11: 2291-2299.
33. Anjaneyulu PSR, Staros JV. Int J Peptide Protein Res 1987; 30: 117-124.
34. Hosoda H, Fukuda K, Gotoh Y. Chem Pharm Bull 1991; 39: 2373-2377.
35. Lomant AJ, Fairbanks G. J Mol Biol 1976; 104: 243-261.
36. Collingridge D, Carroll VA, Glaser M, et al. Cancer Res submitted.
37. O'Kennedy R, Bator JM, Reading C. Anal Biochem 1989; 179: 138-144.
38. Michelot R, Gozlan H, Beaujouan JC, Besson MJ, Torrens Y, Glowinski J. Biochem Biophys Res Commun 1980; 95: 491-498.
39. Bosch R van den, Goeij JJM de, Heide JA van der, Tertoolen JFW, Theelen HMJ, Zegers C. Int J Appl Radiat Isot 1977; 28: 255-261.
40. Glaser M, Brown DJ, Law MP, et al. J Label Compd Radiopharm 2001; 44: 465-480.
41. th Targetry and Target Chemistry Workshop, St. Louis, 23 June 1999: 134-136. http://www.triumf.ca/wttc/99-pdf.html [15 January 2002]